Skip to main content

Abbott

By Mallory Hackett | 10:54 am | June 09, 2020
The study found that the flash continuous glucose monitoring system can cost about 60% less than traditional methods. 
By Laura Lovett | 02:55 pm | June 03, 2020
Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders. 
By Tammy Lovell | 10:39 am | May 15, 2020
The tests give users the option to share information to aid national research into the virus.
By Jonah Comstock | 04:43 pm | February 20, 2020
Both CGM competitors announced integrations with Insulet yesterday during the Advanced Technologies & Treatment for Diabetes Congress in Madrid.
By Dave Muoio | 02:40 pm | January 27, 2020
The system may now be used to target patients' internal globus pallidus, a portion of the brain associated with Parkinson's disease symptoms.
By Dave Muoio | 12:31 pm | January 16, 2020
Bigfoot has agreed to develop and commercialize new programs that will integrate with Abbott's diabetes management platform.
By Dave Muoio | 05:03 pm | June 10, 2019
Onduo, Livongo, Abbott and others also shared news at the show.
By Jonah Comstock | 12:04 pm | February 20, 2019
Abbott joins Dexcom, Glooko and Roche as a data-sharing partner for the as-yet-unlaunched device.
By Jonah Comstock | 06:44 am | November 07, 2018
MobiHealthNews tracked investments, pilots, partnerships and app launches from major pharma companies during the quarter.
By Jonah Comstock | 10:34 am | November 01, 2018
The clearance brings US readers a feature long available in Europe, and paves the way for data plays.